Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre- and Post-LungART

Autor: Ben J. Slotman, Nicolaus Andratschke, Paul Van Houtte, Cécile Le Péchoux, Paul Martin Putora, Rafal Dziadziuszko, Dirk De Ruysscher, Esther G.C. Troost, José Belderbos, Ursula Nestle, Fiona McDonald, Joachim Widder, Umberto Ricardi, X. Geets, Markus Glatzer, Sara Ramella, Matthias Guckenberger, Yolande Lievens, Karin Dieckmann, Farkhad Manapov, Krisztian Süveg, Christoph Pöttgen, Stéphanie Peeters, Corinne Faivre-Finn

Publikováno v: Süveg, K, le Pechoux, C, Faivre-Finn, C, Putora, P M, de Ruysscher, D, Widder, J, van Houtte, P, Troost, E G C, Slotman, B J, Ramella, S, Pöttgen, C, Peeters, S T H, Nestle, U, McDonald, F, Dziadziuszko, R, Belderbos, J, Ricardi, U, Manapov, F, Lievens, Y, Geets, X, Dieckmann, K, Guckenberger, M, Andratschke, N & Glatzer, M 2021, ' Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre-and Post-LungART ', Clinical Lung Cancer, vol. 22, no. 6, pp. 579-586 . https://doi.org/10.1016/j.cllc.2021.08.007
Clinical lung cancer, Vol. 22, no.6, p. 579-586 (2021)
Clinical Lung Cancer, 22(6), 579-586. Elsevier
Clinical Lung Cancer 22(2021)6, 579-586
Clinical Lung Cancer, 22(6), 579-586. CIG Media Group, L.P.

The role of postoperative radiation therapy (PORT) in stage III N2 nonsmall cell lung cancer patients remains controversial. PORT is still widely used among European thoracic radiation oncology experts with a clear decrease in its use for patients wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baf46931e65b1c10e56a0a3ff22721fd
http://www.scopus.com/inward/record.url?scp=85116233138&partnerID=8YFLogxK

Dose mimicking based strategies for online adaptive proton therapy of head and neck cancer

Autor: E Borderias-Villarroel, A Fredriksson, S Cvilic, D Di Perri, E Longton, J Pierrard, X Geets, E Sterpin

Publikováno v: Physics in Medicine and Biology, Vol. 68, no.10, p. N (2023)

Objective. To compare a not adapted (NA) robust planning strategy with three fully automated online adaptive proton therapy (OAPT) workflows based on the same optimization method: dose mimicking (DM). The added clinical value and limitations of the O

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f658b2a7d6dfa39b419c75dc3af94043
https://doi.org/10.1088/1361-6560/accb38

Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine

Autor: Sara Ramella, Stéphanie Peeters, Yolande Lievens, Krisztian Süveg, Cécile Le Péchoux, Markus Glatzer, Ben J. Slotman, Joachim Widder, Nicolaus Andratschke, Christoph Pöttgen, Corinne Faivre-Finn, Umberto Ricardi, Farkhad Manapov, Rafal Dziadziuszko, Karin Dieckmann, Paul Martin Putora, Dirk De Ruysscher, X. Geets, Matthias Guckenberger, Esther G.C. Troost, Ursula Nestle, José Belderbos, Fiona McDonald, Paul Van Houtte

Publikováno v: Radiotherapy and Oncology 154(2021), 269-273
Radiotherapy and Oncology, 154, 269-273. Elsevier Ireland Ltd

Background: Whole brain radiotherapy (WBRT) is a common treatment option for brain metastases secondary to non-small cell lung cancer (NSCLC). Data from the QUARTZ trial suggest that WBRT can be omitted in selected patients and treated with optimal s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8326094b3ceaee02b30211edc97cb34
https://doi.org/10.1016/j.radonc.2020.10.043